Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03897179 · ClinicalTrials.gov registry record · NA

INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study

A NA study, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
27
Enrollment target

NCT03897179 is a NA study that has completed, run by Masimo Corporation. The registered enrollment target is 27 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03897179, a NA study, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target

Study Summary

This study compares the performance of respiration rate from pleth measured prospectively with either INVSENSOR00032 and/or INVSENSOR00033 devices against the respiration rate derived from the manual scoring of the capnography waveform in healthy adult subjects.

Interventions

  • DEVICE INVSENSOR00032 and INVSENSOR00033

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2019-02-13
Est. Completion 2019-02-25
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT03897179

The ClinicalTrials.gov registry entry for NCT03897179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which INVSENSOR00032 and INVSENSOR00033 is the first listed.

NCT03897179 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03897179 about?

NCT03897179 is a clinical study titled "INVSENSOR00032 and INVSENSOR00033 Respiration Rate Clinical Performance Study". This study compares the performance of respiration rate from pleth measured prospectively with either INVSENSOR00032 and/or INVSENSOR00033 devices against the respiration rate derived from the manual scoring of the capnography waveform in healthy adult subjects.

What is the current status of trial NCT03897179?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2019-02-13. Estimated completion is 2019-02-25.

What interventions are being tested in trial NCT03897179?

The interventions under investigation include: INVSENSOR00032 and INVSENSOR00033 (DEVICE).

Who is sponsoring clinical trial NCT03897179?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.